Little Green Pharma Ltd (ASX:LGP)

Australia · Delayed Price · Currency is AUD

0.1100

0.00 (0.00%)

Mar 4, 2026, 3:57 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Pharmaceuticals	36.86M	27.29M	19.86M	14.04M	7.00M
Pharmaceuticals Growth	35.07%	37.41%	41.45%	100.47%	217.77%
Total	36.86M	27.29M	19.86M	14.04M	7.00M
Total Growth	35.07%	37.41%	41.45%	100.47%	217.77%

Revenue by Geography

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia	34.26M	25.29M	19.04M	13.85M	-
Australia Growth	35.47%	32.81%	37.51%	-	-
Europe	13.53M	11.75M	3.39M	824.16K	-
Europe Growth	15.10%	246.37%	311.65%	-	-
Intersegment Eliminations	-10.95M	-11.24M	-2.58M	-633.70K	-
Total	36.84M	25.80M	19.86M	14.04M	-
Total Growth	42.78%	29.93%	41.45%	-	-

Source: S&P Global Market Intelligence.